JP has said on more than one occasion that they are fielding interest from big pharma, but he stated previously that if recent ph11 trials were positive their interest would become stronger. He has since become very quiet on that front. Doesn’t mean they aren’t talking, the silence is deafening, it will be interesting to see how it all plays out.
- Forums
- ASX - By Stock
- NEU
- Share Price
Share Price, page-11782
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$16.71 |
Change
-0.590(3.41%) |
Mkt cap ! $2.135B |
Open | High | Low | Value | Volume |
$17.50 | $17.55 | $16.57 | $10.01M | 594.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 598 | $16.70 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.87 | 1676 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 598 | 16.700 |
1 | 9588 | 16.680 |
1 | 1380 | 16.670 |
1 | 468 | 16.660 |
1 | 50 | 16.600 |
Price($) | Vol. | No. |
---|---|---|
16.870 | 1676 | 1 |
16.880 | 1600 | 2 |
16.910 | 1676 | 1 |
16.950 | 1676 | 1 |
16.980 | 1900 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online